RadNet, Inc.
NASDAQ:RDNTMedical - Diagnostics & Research
+$1.53 today
- Market cap
- $5.66B
- Beta
- 1.39
- P/E (TTM)
- -295.1
- EPS (TTM)
- -$0.18
Volume 0.81M
Average 0.80M
RDNT Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
RadNet, Inc.NASDAQ: RDNT
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue grows in line with its trailing trend
Q3 FY2026 cost of revenue of $552.38M rose 22.6% year over year, behind the +23.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 3.3% from the prior quarter. Over 3 fiscal years it compounded at +15.5% a year.
Context
- Cost of revenue amounted to 95.5% of revenue in FY2025, up 9.2 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +22.6% toward the trailing-twelve-month pace of +23.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 1.95B USD
- Year-over-year change
- +23.3%
- 4-year CAGR
- +14.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.95B | +23.3% |
| FY2024 | 2024-12-31 | 1.58B | +13.3% |
| FY2023 | 2023-12-31 | 1.4B | +10.4% |
| FY2022 | 2022-12-31 | 1.26B | +12.6% |
| FY2021 | 2021-12-31 | 1.12B | — |
Cost of Revenue vs competitors
How RDNT compares with its peers on the latest reported figures
- RDNT's LTM Sep 2026 cost of revenue of $2.15B is the 2nd highest of the 7 companies compared; the peer median is $479.09M.
- Its year-over-year change of +23.3% is the 2nd highest of 7, against a peer median of +10.7%.
- Cost of revenue amounts to 90.2% of revenue for RDNT, versus a peer median of 55.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $11.56B | -1.0% | +3.5% | 57.1% | |
| LTM Sep 2026 | $2.15B | +23.3% | +15.5% | 90.2% | |
| LTM Jun 2026 | $1.87B | +4.7% | +14.9% | 53.3% | |
LMRILumexa Imaging Holdings, Inc. Common Stock | FY2025 | $905.9M | +6.3% | — | 88.5% |
| LTM Mar 2026 | $52.28M | +55.2% | +15.2% | 50.8% | |
| LTM Dec 2025 | $25.81M | +17.4% | +18.6% | 198.2% | |
| LTM Mar 2026 | $19.99M | +15.2% | +17.5% | 23.2% | |
| Peer median (excluding RDNT) | $479.09M | +10.7% | +15.2% | 55.2% | |
Competitors are the stored peer set for RDNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.43B | 1.62B | 1.83B | 2.04B |
| Cost of Revenue | 1.12B | 1.26B | 1.4B | 1.58B | 1.95B |
| Gross Profit | 191.8M | 165.72M | 221.39M | 249.12M | 90.8M |
| Gross Margin | 14.6% | 11.6% | 13.7% | 13.6% | 4.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 109.25M | 119.35M | 122.69M | 144.49M | 0 |
| Depreciation & Amortization | 170.66M | 184.72M | 189.49M | 137.84M | 152.13M |
| EBITDA | 278.37M | 278.53M | 292.79M | 262.55M | 253.95M |
| EBITDA Margin | 21.2% | 19.5% | 18.1% | 14.3% | 12.4% |
| Operating Income | 82.55M | 46.36M | 98.7M | 104.62M | 90.8M |
| Operating Margin | 6.3% | 3.2% | 6.1% | 5.7% | 4.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 48.83M | 50.84M | 64.48M | 79.85M | 69.91M |
| Other Income / Expenses | (23.68M) | (3.39M) | (59.89M) | (59.76M) | (58.9M) |
| Income Before Tax | 58.88M | 42.97M | 38.81M | 44.86M | 31.91M |
| Pre-Tax Margin | 4.5% | 3.0% | 2.4% | 2.5% | 1.6% |
| Income Tax Expense | 14.56M | 9.36M | 8.47M | 6.03M | 14.86M |
| Net Income | 24.73M | 10.65M | 3.04M | 2.79M | (18.65M) |
| Net Margin | 1.9% | 0.7% | 0.2% | 0.2% | -0.9% |
| EPS (Basic) | 0.47 | 0.19 | 0.05 | 0.04 | (0.25) |
| EPS (Diluted) | 0.46 | 0.17 | 0.05 | 0.04 | (0.25) |
| Weighted Avg Shares | 52.5M | 56.29M | 63.58M | 73.04M | 75.19M |
| Weighted Avg Shares (Diluted) | 53.42M | 57.32M | 64.66M | 74.76M | 75.19M |
RadNet, Inc.
NASDAQ:RDNT
Intrinsic Alpha fair value
Locked
Current Price
$71.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.